Smithfield Trust’s HCA Healthcare HCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $212K | Buy |
450
+80
| +22% | +$40.3K | 0.01% | 363 |
|
|
2025
Q4 | $172K | Buy |
370
+25
| +7% | +$11.6K | 0.01% | 382 |
|
|
2025
Q3 | $147K | Hold |
345
| – | – | 0.01% | 393 |
|
|
2025
Q2 | $132K | Hold |
345
| – | – | 0.01% | 402 |
|
|
2025
Q1 | $120K | Hold |
345
| – | – | 0.01% | 411 |
|
|
2024
Q4 | $105K | Hold |
345
| – | – | 0.01% | 438 |
|
|
2024
Q3 | $142K | Hold |
345
| – | – | 0.01% | 397 |
|
|
2024
Q2 | $111K | Hold |
345
| – | – | 0.01% | 421 |
|
|
2024
Q1 | $113K | Hold |
345
| – | – | 0.01% | 427 |
|
|
2023
Q4 | $92K | Hold |
345
| – | – | 0.01% | 447 |
|
|
2023
Q3 | $85K | Hold |
345
| – | – | 0.01% | 444 |
|
|
2023
Q2 | $105K | Hold |
345
| – | – | 0.01% | 415 |
|
|
2023
Q1 | $90K | Hold |
345
| – | – | 0.01% | 438 |
|
|
2022
Q4 | $82K | Hold |
345
| – | – | 0.01% | 439 |
|
|
2022
Q3 | $65K | Hold |
345
| – | – | ﹤0.01% | 461 |
|
|
2022
Q2 | $59K | Hold |
345
| – | – | ﹤0.01% | 510 |
|
|
2022
Q1 | $87K | Hold |
345
| – | – | 0.01% | 459 |
|
|
2021
Q4 | $89K | Hold |
345
| – | – | 0.01% | 469 |
|
|
2021
Q3 | $84K | Hold |
345
| – | – | 0.01% | 464 |
|
|
2021
Q2 | $72K | Hold |
345
| – | – | ﹤0.01% | 495 |
|
|
2021
Q1 | $65K | Hold |
345
| – | – | ﹤0.01% | 511 |
|
|
2020
Q4 | $57K | Buy |
345
+40
| +13% | +$5.85K | ﹤0.01% | 502 |
|
|
2020
Q3 | $38K | Hold |
305
| – | – | ﹤0.01% | 547 |
|
|
2020
Q2 | $30K | Buy |
305
+150
| +97% | +$15.6K | ﹤0.01% | 562 |
|
|
2020
Q1 | $14K | Hold |
155
| – | – | ﹤0.01% | 629 |
|
|
2019
Q4 | $23K | Hold |
155
| – | – | ﹤0.01% | 606 |
|
|
2019
Q3 | $19K | Sell |
155
-100
| -39% | -$12.9K | ﹤0.01% | 656 |
|
|
2019
Q2 | $35K | Sell |
255
-1,040
| -80% | -$131K | ﹤0.01% | 565 |
|
|
2019
Q1 | $169K | Hold |
1,295
| – | – | 0.02% | 279 |
|
|
2018
Q4 | $161K | Sell |
1,295
-110
| -8% | -$14.8K | 0.02% | 266 |
|
|
2018
Q3 | $196K | Buy |
1,405
+410
| +41% | +$51K | 0.02% | 287 |
|
|
2018
Q2 | $102K | Buy |
995
+840
| +542% | +$85K | 0.01% | 395 |
|
|
2018
Q1 | $15K | Hold |
155
| – | – | ﹤0.01% | 664 |
|
|
2017
Q4 | $14K | Buy |
+155
| New | +$12.5K | ﹤0.01% | 705 |
|
|
2015
Q4 | – | Sell |
-970
| Closed | -$75K | – | 841 |
|
|
2015
Q3 | $75K | Sell |
970
-13
| -1% | -$1.15K | 0.02% | 418 |
|
|
2015
Q2 | $89K | Buy |
+983
| New | +$78.8K | 0.02% | 407 |
|
Other funds holding HCA
VCM
VPM
Smithfield Trust's HCA Position: Q1 2026 in Review
Smithfield Trust increased its HCA Healthcare (HCA) stake by 22% in Q1 2026, buying an estimated $40.3K and bringing the position to 450 shares worth $212K. The position accounts for 0.01% of the portfolio, ranked #363.
Smithfield Trust first reported a position in HCA in Q2 2015 and has held it in 36 quarters since. 1,414 funds tracked by Wall St. Rank hold HCA as of Q1 2026.
- Smithfield Trust held 450 shares of HCA Healthcare worth $212K as of Q1 2026.
- Smithfield Trust bought 80 HCA Healthcare shares in Q1 2026, an estimated $40.3K.
- HCA Healthcare made up 0.01% of Smithfield Trust's portfolio in Q1 2026, its #363 holding.
- Smithfield Trust first reported a position in HCA Healthcare in Q2 2015 and has held it in 36 quarters since.
- 1,414 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.
Based on Smithfield Trust's 13F filing for Q1 2026, filed 8 May 2026.